Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anisodamine hydrobromide with opioids for painless colonoscopy
ChiCTR2300070167Phase 4Recruiting
- Sponsor
- Weifang People's Hospital
- Start
- Apr 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of raceanisodamine, ciprofol, alfentanil and remifentanil in None (2 arms), sponsored by Weifang People's Hospital. Primary endpoints: Degree and number of intestinal spasms, Additional drug use and 2 more. Started Apr 2023; status: recruiting.
02
Drugs
raceanisodamineciprofolalfentanilremifentanil
Beyond the preview
Go deeper on ChiCTR2300070167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070167.